These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3123079)

  • 1. Further characterization of the in vitro and in vivo activity of ciprofloxacin against mycoplasmas.
    Furneri PM; Tempera G; Chiarenza A; Caccamo F; Speciale AM; Nicoletti G
    Chemioterapia; 1987 Oct; 6(5):346-9. PubMed ID: 3123079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Rylander M; Hallander HO
    Scand J Infect Dis Suppl; 1988; 53():12-7. PubMed ID: 2843982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.
    Waites KB; Duffy LB; Schmid T; Crabb D; Pate MS; Cassell GH
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1181-5. PubMed ID: 1929260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years.
    Krausse R; Schubert S
    Clin Microbiol Infect; 2010 Nov; 16(11):1649-55. PubMed ID: 20047607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of several antimicrobial agents against genital mycoplasmas.
    Echániz Avilés G; Conde González C; Juárez Figueroa L; Carnalla Barajas N; Tamayo Legorreta E; Calderón Jaimes E
    Clin Ther; 1992; 14(5):688-95. PubMed ID: 1468088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative activity of minocycline and doxycycline on mycoplasmas pathogenic for man].
    Bebear C; Cantet P; Renaudin H; Quentin C
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):577-80. PubMed ID: 3937130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
    Rumpianesi F; Sambri V; Bertini S; Tamba I; Cevenini R
    Chemioterapia; 1984 Jun; 3(3):173-4. PubMed ID: 6529772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis of mycoplasma infections.
    Senterfit LB
    Isr J Med Sci; 1984 Oct; 20(10):905-7. PubMed ID: 6439677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of lymecycline on pathogenic mycoplasmas].
    Bonissol C; Stoiljkovic B; Kona P; Fleury J
    Pathol Biol (Paris); 1983 Jun; 31(6):492-6. PubMed ID: 6410346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-mycoplasmal activity of a new macrolide: miocamycin.
    Furneri PM; Tempera G; Bisignano G; Cottarelli FV; Nicoletti G
    Chemioterapia; 1987 Oct; 6(5):341-5. PubMed ID: 3501335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae.
    Gohara Y; Arai S; Akashi A; Kuwano K; Tseng CC; Matsubara S; Matumoto M; Furudera T
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1826-30. PubMed ID: 8239590
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Xue G; Crabb DM; Xiao L; Liu Y; Waites KB
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimycoplasmal activities of (S)-(-)-9-fluoro-2,3-dihydro-3-methyl-10 -[4-(2-pyridyl)-1-piperazinyl]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine -6-carboxylic acid (YH-6) in comparison with other antibiotics in vitro.
    Ye H; Wu JM; Yang YS; Ji RY; Chen KX
    Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):1031-4. PubMed ID: 11270970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of genital Mycoplasma and Ureaplasma infections.
    Friberg J
    J Reprod Med; 1985 Mar; 30(3 Suppl):258-61. PubMed ID: 4020782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of trospectomycin sulphate against Mycoplasma and Ureaplasma species isolated from humans.
    Yancey RJ; Klein LK
    J Antimicrob Chemother; 1988 Jun; 21(6):731-6. PubMed ID: 2970452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antimycoplasmal activity of mepartricin.
    Meloni GA; Busolo F; Bortolon P; Ruozi P
    Farmaco Sci; 1979 Mar; 34(3):183-8. PubMed ID: 118890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal study on the therapy of Mycoplasma pneumoniae infections with ciprofloxacin on Syrian hamsters.
    Furneri P; Tempera G; Caccamo F; Speciale A; Nicoletti G
    Chemioterapia; 1987 Jun; 6(2 Suppl):181. PubMed ID: 3151338
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates.
    García-Castillo M; Morosini MI; Gálvez M; Baquero F; del Campo R; Meseguer MA
    J Antimicrob Chemother; 2008 Nov; 62(5):1027-30. PubMed ID: 18753188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activities of investigational peptide deformylase inhibitor NVP LBM-415 and other agents against human mycoplasmas and ureaplasmas.
    Waites KB; Reddy NB; Crabb DM; Duffy LB
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2541-2. PubMed ID: 15917568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and antimicrobial susceptibilities of genital mycoplasmas in outpatient women with clinical vaginitis in Athens, Greece.
    Kechagia N; Bersimis S; Chatzipanagiotou S
    J Antimicrob Chemother; 2008 Jul; 62(1):122-5. PubMed ID: 18424791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.